Top 5 Indian Generic Medicine Suppliers in Latin America

1
(No Transcript)
2
Top 5 Indian Generic Medicine Suppliers in Latin
America

• The demand for generic Medicine / Drugs is
  increasing in Latin America, and Indian
  pharmaceutical companies realize this
  opportunitys great potential. Efficient and
  affordable medicines are always required, making
  this a flourishing market for drug makers.
• The worldwide generic drugs market is forecasted
  to increase at a compound annual growth rate
  (CAGR) of 8.7, meaning that, in the projection
  period 2016 to 2021, the worldwide market will
  rise from almost 352 billion to 533 billion.

3
Top 5 Indian Generic Medicine Suppliers in Latin
America

• In this article, the top five Indian generic
  pharmaceuticals suppliers, manufacturers and
  distributors are listed

• JoinHub Pharma
• Dr. Reddy
• Teva Pharmaceutical
• Cipla
• Lupin

4
JoinHub Pharma

• JoinHub Pharma is an award-winning Pharmaceutical
  Company in India. We hold a reputed name with
  regards to branded medicines and generic
  medicines.
• Our company is certified by the highest
  authority like WHO, FDA, ISO 90012008, GMP, etc.
  We are a top generic pharma manufacturer,
  supplier, and distributor in Latin America and
  are known for our top-of-the-line quality pharma
  products and services. Without a doubt, we are
  considered to be one of the best generic
  pharmaceutical companies in India.
• In fact, 85 of our revenue is generated by way
  of exporting to MIDDLE EAST, CIS, and AFRICA
  production facilities. We are famous for our
  widest list of medicines which contains more than
  1000 pharma products.

5
JoinHub Pharma

• Based in India, JoinHub Pharma is a generic
  pharma company in India with a broad footprint
  covering the US, Europe, South-East Asia, Middle
  East, and South Africa.
• It manufactures more than 200 generic drugs and
  complex APIs in a wide range of therapeutic
  areas, including cardiovascular, diabetes, HIV,
  oncology, infectious diseases, hepatitis,
  ophthalmology, urology, neurosciences,
  respiratory, and womens health.

6
Dr. Reddy

• The global generics segment of Dr. Reddys
  accounted for approximately 80 of the companys
  revenue in 2018, with North America being the
  biggest contributor.
• As of March 2018, the company filed 20
  abbreviated new drug applications (ANDAs) and had
  110 generic filings pending approval with the US
  FDA. Moreover, it launched five
  first-generic-to-launch (FGTL) products in
  Brazil.
• Based in India, Dr. Reddys is an Indian
  pharmaceutical company whose generic formulations
  business offers more than 200 high-quality
  generic medicines worldwide, with over 20 assets
  falling under the complex generics category,
  including decitabine, fondaparinux, and
  azacitidine injections.
• The companys generic formulations segment
  includes tablets, capsules, injectables, and
  topical creams. Nise (Nimesulide), Stamlo
  (Amlodipine Besylate), Omez (Omeprazole), and
  Razo (Rabeprazole) are a couple of its products
  available in Latin Americas emerging markets.

7
Teva Pharmaceutical

• Teva Pharmaceuticals 2018 revenues in North
  America decreased by 22 as compared to 2017
  because of the price erosion and volume
  reductions. They have launched generic versions
  of medicines such as Solodyn, Aloxi, Syprine,
  Estrace, Lialda, Uceris, and Elidel in the
  region in 2018.
• The companys European revenues increased by 4
  to 3.6bn, compared to 2017. The revenue growth
  resulted from an increase in OTC medicine sales
  and the launch of new pharma products, which
  offset the impact of price cuts of generics in
  the first half of 2018. However, the overall
  revenue was affected marginally in the second
  half of 2018 because of the dismissal of Tevas
  joint venture with PGT Healthcare.
• Teva Pharmaceuticals offers diverse products in
  various segments such as specialty, generic, OTC,
  and APIs.

8
Cipla

• Ciplas revenues progressed marginally compared
  to the earlier year, with the generics business
  in Latin America contributing around 21 to the
  domestic business revenues as of March 2018.
• The company was ranked as one of the top ten
  generic Pharma manufacturers in the US, with 13
  out of 52 products ranked as number one,
  according to IQVIA IMS RQTR as of March 2018.
• Cipla is working to develop complex generic
  formulations based on nanotechnology for the US
  market.

9
Lupin

• Lupins generics business held 90 of the
  companys total revenues in the US in 2018. It
  was established in 1968, and while its primary
  focus is generic drugs, it additionally produces
  branded medicines and API (active pharmaceutical
  ingredients).
• Lupin filed 20 generic products in many
  geographic regions worldwide, which includes the
  APAC (Japan Australia), Canada, EMEA (Europe,
  Middle East, and Africa), and Latin America
  (Brazil Mexico), and got 22 approvals in 2018.
• Lupin also got 24 ANDA approvals out of 36 ANDA
  files in the US in 2018. Lupin is a pharma
  company based in India with many segments,
  including generic products, biotechnology
  products, complex generics, APIs, and specialty.

10

• If youre looking for generic medicines at an
  affordable rate, contact JoinHub Pharma a
  leading generic pharma company in India.
• JoinHub Pharma is a top generic pharma export
  company offering affordable manufacturing
  business deals. All our products are highly
  qualitative in all terms. With our specialization
  divisions, we assure you of the best formulation.
• Simply drop them an email at info_at_joinhubpharma.co
  m or call directly on 91 97247 25604.

11
Contact Us Today For All Your Requirement Related
To Pharmaceutical Products
www.joinhubpharma.com
info_at_joinhubpharma.com
91 97247 25604
A/204, Siddhi Vinayak Business Park, Nr.kataria
Automobiles Ltd, Makarba. S.G.Road,
Ahmedabad-380051 Gujarat (India).